載入...
Ivermectin & COVID-19: Let's keep a One Health perspective
Despite uncertainty about its clinical benefit, ivermectin has been used for COVID 19, even in prophylaxis. The European Medicines Agency (EMA) has advised against its use for the prevention or treatment of COVID-19 outside randomised clinical trials. Although the potential negative environmental ef...
Na minha lista:
| 發表在: | Sustain Chem Pharm |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier B.V.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053244/ https://ncbi.nlm.nih.gov/pubmed/33898692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scp.2021.100438 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|